Viral Infections

  • Author: Jin S. Suh, MD, FACP (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 7/26/16 (What's New)

Summary

  • CMV disease is best prevented by initiating and continuing ART to maintain a CD4+ cell count > 100 cells/mm3
  • Patients who have CD4+ cell counts < 100 cells/mm3 should have an annual screening by indirect ophthalmoscopy
  • Valganciclovir is the preferred treatment for maintenance therapy for CMV retinitis (Table 5) (Management Guidelines)[CDC OI]

Action required